Zip Bio
- Biotech or pharma, therapeutic R&D
ZipBio is a biotechnology company pioneering the development of advanced protein therapeutics through COMPACT, its proprietary generative AI platform for de novo protein design.
The COMPACT platform enables the creation of compact, smart, and multifunctional biologics designed to overcome the inherent limitations of traditional modalities. By optimizing for size, stability, and multi-target engagement, ZipBio is unlocking new therapeutic possibilities across a range of disease areas, including immunology, cardiometabolic disorders, oncology, and ophthalmology.
We are actively seeking to engage with pharmaceutical companies and investors interested in partnering to co-develop or advance novel protein-based therapies.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}